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A Mg-ATP-dependent protein phosphatase has been reconstituted from the catalytic subunit of protein 
phosphatase-1 and inhibitor-2, and consists of a 1: 1 complex between these proteins. Activation of this 
enzyme by glycogen synthase kinase-3 and Mg-ATP results from the phosphorylation of inhibitor-2 on a 
threonine residue(s) and is accompanied by the dissociation of the complex. The results prove that protein 
phosphatase-1 and the Mg-ATP-dependent protein phosphatase contain the same catalytic subunit, and 
that they are interconvertible forms of the same enzyme. 
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1. INTRODUCTION 
The Mg-ATP-dependent protein phosphatase, 
an enzyme first described in adrenal cortex by 
Merlevede and Riley [ 11, is now known to have a 
ubiquitous tissue distribution [2-41. It consists of 
an inactive protein phosphatase that must first be 
preincubated with Mg-ATP and an activating pro- 
tein in order to exhibit biological activity [2,3]. The 
activating protein was shown to be associated with 
glycogen synthase kinase activity [5], and purifica- 
tion to near homogeneity has established its identi- 
ty as the enzyme glycogen synthase kinase-3 
(GSK-3) [6]. This finding suggested that the activa- 
tion process should involve a phosphorylation 
mechanism [6,7], but this idea has been disputed 
18,91. 
The substrate specificity and regulatory proper- 
ties of the Mg-ATP-dependent protein phospha- 
tase are remarkably similar to those of protein 
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phosphatase-1 [lo]. Furthermore, it has been 
reported that inhibitor-2, a thermostable protein 
that inhibits protein phosphatase-1 specifically 
[lo], is involved in the inactivation and reactiva- 
tion of the Mg-ATP-dependent protein phospha- 
tase [ 11,121. These findings led us to try to recon- 
stitute the Mg-ATP-dependent protein phospha- 
tase from homogeneous preparations of protein 
phosphatase-1 and inhibitor-2. We have now 
established that by preincubating these two pro- 
teins, a 1: 1 complex is produced whose properties 
are indistinguishable from the Mg-ATP-dependent 
protein phosphatase (T. J.R., B.A.H., H.Y. Lim 
Tung, P.C., in preparation). Here, we demonstrate 
that the activation mechanism does involve a 
phosphorylation reaction. 
2. MATERIALS AND METHODS 
2.1. Materials 
[35S]Adenosine-5’-O-(3-thio) triphosphate 
[ATP+] was purchased from New England 
Nuclear, and unlabelled ATPyS from Boehringer. 
[Y-~~P]ATP and [~u-~~P]ATP were from Amersham 
International, Sephadex G-100 (Superfine grade) 
and blue Sepharose CL-6B from Pharmacia, and 
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DEAE-cellulose (DE-52) from Whatman. 
Phosphorylase b [ 131, [32P]phosphorylase a
[ 10,141, phosphorylase kinase [ 151 and GSK-3 
[6,16] were purified from rabbit skeletal muscle by 
standard procedures. 
2.2. Isolation of protein phosphatase-1 and 
inhibitor-2 from rabbit skeletal muscle 
The M, 33 000 catalytic subunit of protein 
phosphatase-1 was purified to homogeneity by a 
modification of the procedure in [ 171. The pro- 
cedure involved precipitation with ammonium 
sulphate and ethanol as in [17] followed by 
chromatography on DEAE-cellulose and 
polylysine-Sepharose at pH 7.5, and gel filtration 
on Sephadex-100. The preparation showed a single 
protein-staining band on SDS-polyacrylamide gels 
(app. M, 33 000) and had spec. act. 
-50 000 U/mg (section 2.5). Its properties were 
indistinguishable from protein phosphatase-1 
isolated by other methods [lo] as judged by the 
criteria in [18]. 
Inhibitor-2 was purified to homogeneity as in 
[19]. At the final chromatography on blue Sepha- 
rose, the protein was eluted at 0.1 M NaCl, rather 
than at 0.6 M NaCl as in [19]. The preparation 
showed a single protein staining band on SDS- 
polyacrylamide gels (app. M, 33 000) and had spec. 
act. -50 000 U/mg (section 2.5). Its properties 
were indistinguishable from protein phosphatase-1 
isolated by other methods [lo] as judged by the 
criteria in [18]. 
Inhibitor-2 was purified to homogeneity as in 
[ 191. At the final chromatography on blue Sepha- 
rose, the protein was eluted at 0.1 M NaCl, rather 
than at 0.6 M NaCl as in [19]. The preparation 
showed a single protein staining band on 
SDS-polyacrylamide gels, M, 30 500. Its specific 
activity, electrophoretic mobility and amino acid 
composition were essentially identical to those of 
inhibitor-2 isolated as in [20]. 
2.3. Preparation of the Mg-A TP-dependen t 
protein phosphatase and dephosphorylated 
inhibitor-2 
Equimolar proportions of protein phosphatase-1 
and inhibitor-2 were incubated for l-2 h at 30°C 
in 20 mM Tris-HCl (pH 7.0)-10% glycerol-O. 1% 
(v/v) 2-mercaptoethanol. The solution was then 
applied to a 1.0 x 1 .O cm column of blue Se- 
320 
pharose equilibrated in the same buffer. The 1: 1 
complex of inhibitor-2 and protein phosphatase-1 
passed through the column, while any uncombined 
inhibitor-2 and protein phosphatase-1 were retain- 
ed. Full details of the preparation and characterisa- 
tion of this reconstituted Mg-ATP-dependent pro- 
tein phosphatase will be presented elsewhere 
(T.J.R., B.A.H., H.Y. Lim Tung, P.C., in 
preparation). 
The prolonged incubation of protein 
phosphatase-1 and inhibitor-2 ensured that the lat- 
ter protein was completely dephosphorylated. Ali- 
quots of the preparation were therefore heated at 
100°C for 10 min and centrifuged to remove pro- 
tein phosphatase-1, which is completely denatured 
by this treatment. The supernatant was used as the 
source of dephosphorylated inhibitor-2 in the ex- 
periment in fig. 3 (section 3). 
2.4. Phosphorylation and thiophosphorylation of 
the Mg-ATP-dependent protein phosphatase 
The Mg-ATP-dependent protein phosphatase 
(0.02 mg/ml) was activated at 30°C in an incuba- 
tion (0.15 ml) containing GSK-3, 50 mM 
Tris-HCl (pH 7.0) (25”(Z)-0.1 mM EDTA-0.1% 
(v/v) 2-mercaptoethanol-0.01% Brij 35, 2.0 mM 
magnesium acetate and 0.5 mM [Y-~~P]ATP (lo9 
cpm/pmol). At various times, aliquots were 
removed and used to measure activation and 
phosphorylation. Thiophosphorylation was car- 
ried out in an identical manner except that 
[35S]ATPyS was substituted for [Y-~~P]ATP. In 
calculating the phosphorylation or thiophospho- 
rylation stoichiometry, the M, of the Mg-ATP- 
dependent protein phosphatase was taken as 
63 500 (protein phosphatase-1 = 33 000, inhi- 
bitor-2 = 30 500) and protein concentrations were 
determined as in [21] using bovine serum albumin, 
/, 1% 
280 nm = 6.5, as a standard. 
2.5. Assay of the Mg-ATP-dependent protein 
phosphatase and protein phosphatase-1 
Both enzymes were assayed at 30°C by the 
release of 32Pi from [32P]phosphorylase a. The 
assays (0.06 ml) contained phosphorylase a 
(1.0 mg/ml), 50 mM Tris-HCl pH 7.0 (25”(Z), 
0.1 mM EDTA, 0.1% (v/v) 2-mercaptoethanol, 
5 mM caffeine and 0.6 mg bovine serum 
albumin/ml. Assays of the Mg-ATP-dependent 
protein phosphatase also contained 1.25 mM 
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Fig. 1. Activation and phosphorylation of the Mg-ATP-dependent protein phosphatase. The Mg-ATP-dependent pro- 
tein phosphatase, GSK-3 and [y-32P]ATP were incubated at 30°C as in section 2.4. The reactions were initiated with 
Mg-ATP, and at the times indicated aliquots were diluted with 50 mM Tris-HCl pH 7.0 (25”(Z), 0.5 mM EDTA, 0.1% 
(v/v) 2-mercaptoethanol, 1 .O mg bovine serum albumin/ml. The diluted enzyme was assyed directly and after maximal 
activation by GSK-3 and Mg-ATP in order to determine the percentage conversion to the active form (M). Further 
aliquots were analysed for the incorporation of “P radioactivity (m): (A) 20 gg Mg-ATP-dependent protein phos- 
phatase were incubated with 0.3 pg of GSK-3, and the reactions diluted 200-fold before assay; (B) 20 pg Mg-ATP- 
dependent protein phosphatase were incubated for 1 min with different concentrations of GSK-3 (O-l. 1 fig), and the 
reactions diluted 20-fold before assay. 
magnesium acetate-O.125 mM ATP and GSK-3. 
The Mg-ATP-dependent protein phosphatase was 
assayed as in [6] and protein phosphatase-1 as in 
[20]. Reactions were terminated and analysed as in 
[20]. One unit of protein phosphatase was that 
amount which catalysed the release of 1.0 nmol 
phosphate/min in the above assays. Further details 
are given in the legends to the figures presented in 
section 3. 
3. RESULTS 
3.1. Phosphorylation of the reconstituted 
Mg-A TP-dependent protein phosphatase 
The enzyme was completely inactive until in- 
cubated with GSK-3 and Mg-ATP. GSK-3 (0.3 pg) 
(6 pmol [6]) was capable of activating 20 pg 
(300 pmol) of Mg-ATP-dependent protein 
phosphatase (fig. 1A) demonstrating that GSK-3 
was acting catalytically. 
To investigate the activation mechanism, ex- 
periments were carried out using [32P]-labelled 
ATP. These studies showed that activation was ac- 
companied by a rapid incorporation of [32P]- 
radioactivity into the preparation using 
[T-~~P]ATP (fig. 1A) but not [~u-~~P]ATP (not 
shown). All the 32P radioactivity was incorporated 
into inhibitor-2 and -90% was present as 
phosphothreonine. Phosphoserine accounted for 
- 10% of the radioactivity, while phosphotyrosine 
was completely absent (not shown). 
A linear relationship between phosphorylation 
and activation could be demonstrated uring the 
first minute of activation, when incubations were 
performed using a range of GSK-3 concentrations 
(fig. 1B). At later time points, however, the level 
of phosphorylation declined, while activation con- 
tinued to increase. The lack of correlation between 
phosphorylation and activation is explained in sec- 
tion 3.4. 
321 
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Fig. 2. Gel filtration of protein phosphatase-1 (A), inac- 
tive Mg-ATP-dependent protein phosphatase (B) and ac- 
tivated Mg-ATP-dependent protein phosphatase (C) on 
Sephadex G-100 Superfine (45 x 1.7 cm). The column 
was equilibrated in 50 mM Tris-HCI (pH 7.0)-O. 1% 
(v/v) 2-mercaptoethanol-10% (v/v) glycerol-2.0 mM 
magnesium acetate-O.2 mM ATP, except for (A) in 
which Mg-ATP was omitted. Samples (0.5 ml) contain- 
ing lo-20 U protein phosphatase activity were applied 
to the column, and fractions of 1.0 ml collected at 
8 ml/h. Fractions were assayed, without further dilu- 
tion, for protein phosphatase activity in the absence 
(M) or presence (+-o) of Mg-ATP and GSK-3 as 
in section 2.5. The arrows l-4 denote the elution posi- 
tions of the marker proteins yeast alcohol dehydrogenase 
M, = 148 000, bovine serum albumin M, = 68 000, 
ovalbumin M, = 43 000 and carbonic anhydrase 
M, = 29 500, respectively. 
3.2. Dissociation of the Mg-A TP-dependent 
protein phosphatase 
Protein phosphatase-1 and the reconstituted Mg- 
ATP-dependent protein phosphatase migrated as 
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Table 1 
Inactivation of the Mg-ATP-dependent protein 
phosphatase by thiophosphorylation of inhibitor-2 
Time 
(min) 
Thiophosphate 
incorporated 
(mol/mol 
inhibitor-2) 
Phosphatase 
inactivation 
(70) 
0 0 0 
2 0.37 25 
5 0.47 50 
10 0.68 62 
20 0.77 66 
The Mg-ATP-dependent protein phosphatase (32 pg), 
GSK-3 (0.5 pg) and [35S]ATPyS were preincubated at 
30°C in 1 .O ml total vol., as in section 2.4. The reaction 
was initiated with [35S]ATP$$ and at the times 
indicated, aliquots were analysed for incorporation of 
‘%-radioactivity. Further aliquots were diluted 250-fold, 
and the diluted samples assayed directly and after 
maximal activation by GSK-3 and Mg-ATP. The 
inactivation of the enzyme was calculated by reference to 
a control preincubation in which GSK-3 was omitted 
single components on Sephadex G-100 with app. 
M, of 33 000 and 87 000, respectively (fig. 2A,B). 
An app. Mr of 87 000 would be expected, since 
inhibitor-2 is a protein with little ordered structure 
that yields an app. Mr of 65 000 on Sephadex 
G-100 [20,22]. Activation of the Mg-ATP- 
dependent protein by GSK-3 and Mg-ATP was ac- 
companied by its dissociation to protein 
phosphatase-1, I’& 35 000 (fig. 2C). No dissocia- 
tion occurred if GSK-3 was omitted from the in- 
cubations (fig. 2B). The dissociated protein 
phosphatase-1 (fig. 2C) could be reconverted to 
the Mg-ATP-dependent protein phosphatase by 
reincubation with inhibitor-2 (not shown). 
3.3. Thiophosphorylation of inhibitor-2 
It has been reported that ATPyS cannot 
substitute for ATP in the activation of the Mg- 
ATP-dependent protein phosphatase [9], an obser- 
vation confirmed here. However, further ex- 
periments using [35S]ATPyS showed that GSK-3 
catalysed the thiophosphorylation of inhibitor-2, 
and that thiophosphorylation prevented the Mg- 
ATP-dependent protein phosphatase from being 
activated by GSK-3 and Mg-ATP (table 1). The 
thiophosphorylation stoichiometry approached 
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Fig. 3. Conversion of protein phosphatase-1 to the Mg- 
ATP-dependent protein phosphatase by incubation with 
dephosphorylated inhibitor-2 (section 2.2). Protein 
phosphatase-1 (1.3 pg) was incubated at 30°C with 
inhibitor-2 (1.3 pg) in 0.1 ml 50 mM Tris-HCl 
(pH 7.0)-0.5 mM EDTA-0.1% (v/v) 2-mercapto- 
ethanol-l.0 mg bovine serum albumin/ml (M). At 
various times aliquots were diluted lo-fold and assayed 
for conversion to the Mg-ATP-dependent protein phos- 
phatase as in section 2.5: (C----C)) control incubation in 
which inhibitor-2 was omitted. 
1.0 mol/mol after prolonged incubation (table 1). 
These experiments demonstrate that phosphoryla- 
tion of inhibitor-2 is essential for activation, 
although why thiophosphorylation does not mimic 
phosphorylation in this system is unclear. 
3.4. Mechanism of activation and inactivation of 
the Mg-A TP-dependent protein phosphatase 
The conversion of protein phosphatase-1 to the 
Mg-ATP-dependent protein phosphatase is 
relatively slow under the conditions tested, occurr- 
ing with a t, of -15 min, even using 
dephosphorylated inhibitor-2 (fig. 3). This slow 
reassociation accounts for the lack of correlation 
between phosphorylation and activation (fig. l), 
and the simplest model that explains the results is 
illustrated in fig. 4. Activation of the Mg-ATP- 
0 PrP-1 
GSK-3 
/ 
active 
MCJ-ATP 
+ 
inactive active 
Fig. 4. Model for activation of the Mg-ATP-dependent 
protein phosphatase, and its reformation from protein 
phosphatase-1 (PrP-1) and inhibitor-2 (I*). 
dependent protein phosphatase is initiated by the 
phosphorylation of inhibitor-2, which causes its 
dissociation to protein phosphatase-1 (fig. 2C). 
The activated phosphatase can then analyse the 
dephosphorylation of inhibitor-2, the phos- 
phorylation state of this protein being determined 
by the relative activities of GSK-3 and protein 
phosphatase-1. However, provided the reassocia- 
tion of protein phosphatase-1 and dephosphory- 
lated inhibitor-2 is rate-limiting, the extent of acti- 
vation of the Mg-ATP-dependent phosphatase will 
continue to increase, as each inhibitor-2 molecule 
undergoes a phosphorylation-dephosphorylation 
cycle (fig. 4). 
4. DISCUSSION 
The present finding, that activation of the Mg- 
ATP-dependent protein phosphatase is triggered 
by the phosphorylation of inhibitor-2 is at variance 
with the conclusions of Merlevede and coworkers. 
This group purified the Mg-ATP-dependent pro- 
tein phosphatase to a state where it showed one 
major protein, M, 70 000 on SDS-polyacrylamide 
gels, and reported that no 32P-radioactivity was in- 
corporated into this band following incubation 
with GSK-3 and Mg-[r32P]ATP [8,9]. They recent- 
ly suggested that activation and inactivation might 
involve the addition and removal of Mg’+, the ac- 
tivated form of the phosphatase being a 
Mg”-metalloenzyme [9]. It was envisaged that 
GSK-3 catalysed the insertion of Mg2+ into the 
phosphatase from Mg-ATP. This idea stemmed 
from their report that the Mg-ATP-dependent pro- 
tein phosphatase could be partially activated by 
Mnzf , even in the absence of GSK-3 and Mg-ATP 
323 
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191. However, the reconstituted Mg-ATP- 
dependent protein phosphatase used in this study 
cannot be activated by Mn*+ (unpublished). The 
conversion of protein phosphatase-1 to Mn”- 
dependent forms is well documented [23,24], and is 
a phenomenon unrelated to the formation of the 
Mg-ATP-dependent protein phosphatase. It seems 
likely that the enzyme isolated by Merlevede and 
coworkers also contained a Mn*+-dependent form 
of protein phosphatase-1 . 
The nature of the M, 70 000 protein isolated in 
[8] is unclear. One possibility is that the M, 70 000 
protein represents an undegraded form of protein 
phosphatase-1, the M, 33 000 species being an 
active fragment of the enzyme. Alternatively the 
M, 70 000 protein could be an impurity, since 
the specific activities of the preparations, 
10 000 U/mg [8,12], were lower than that of the 
M, 33 000 form of protein phosphatase-1 
(-50 000 U/mg, section 2.2). Further work is 
needed to distinguish between these two 
possibilities. Nevertheless, the finding that 
phosphorylation of inhibitor-2 underlies the ac- 
tivation of the Mg-ATP-dependent protein 
phosphatase explains why phosphorylation of the 
M, 70 000 protein was not detected previously. 
Recent studies of the phosphorylation of 
glycogen synthase in vivo suggest that GSK-3 ac- 
tivity is under the control of insulin. This raises the 
possibility that activation of the Mg-ATP- 
dependent protein phosphatase is also under hor- 
monal control. It will be of considerable interest to 
examine the phosphorylation state of inhibitor-2 in 
vivo and how it changes in response to insulin and 
other hormones. 
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